Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Effect of beta- and alpha-glucans on immune modulating factors expression in enterocyte-like Caco-2 and goblet-like LS 174T cells.

De Felice B, Damiano S, Montanino C, Del Buono A, La Rosa G, Guida B, Santillo M.

Int J Biol Macromol. 2020 Mar 10;153:600-607. doi: 10.1016/j.ijbiomac.2020.03.046. [Epub ahead of print]

PMID:
32165203
2.

Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study.

Kočka V, Toušek P, Kozel M, Buono A, Hajšl M, Lisa L, Buděšínský T, Malý M, Widimský P.

J Transl Med. 2020 Jan 30;18(1):33. doi: 10.1186/s12967-020-02230-1.

3.

QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method.

Buono A, Mühlenhaus A, Schäfer T, Trieb AK, Schmeißer J, Koppe F, Münzel T, Anadol R, Gori T.

J Clin Med. 2020 Jan 14;9(1). pii: E220. doi: 10.3390/jcm9010220.

4.

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study.

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier À, Buono A, Serruys PW, Sabaté M; Collaborators.

EuroIntervention. 2020 Mar 20;15(16):1436-1443. doi: 10.4244/EIJ-D-19-00773.

5.

[Myocardial infarction with non-obstructive coronary arteries (MINOCA): diagnosis, pathogenesis, therapy and prognosis].

Buono A, Pedrotti P, Soriano F, Veas N, Oliva F, Oreglia J, Ammirati E.

G Ital Cardiol (Rome). 2019 Sep;20(9):499-511. doi: 10.1714/3207.31839. Review. Italian.

PMID:
31530951
6.

No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient.

Buono A, Gori T.

Int J Cardiol Heart Vasc. 2019 Aug 30;24:100417. doi: 10.1016/j.ijcha.2019.100417. eCollection 2019 Sep. No abstract available.

7.

Getting to the heart of the matter in a multisystem disorder: Erdheim-Chester disease.

Buono A, Bassi I, Santolamazza C, Moreo A, Pedrotti P, Sacco A, Morici N, Giannattasio C, Oliva F, Ammirati E.

Lancet. 2019 Aug 17;394(10198):e19. doi: 10.1016/S0140-6736(19)31787-8. No abstract available.

PMID:
31423997
8.

Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.

Fadini GP, Frison V, Simioni N, Lapolla A, Gatti A, Bossi AC, Del Buono A, Fornengo P, Gottardo L, Laudato M, Perseghin G, Bonora E, Avogaro A.

J Am Heart Assoc. 2019 Jul 16;8(14):e012244. doi: 10.1161/JAHA.119.012244. Epub 2019 Jul 4.

9.

Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.

Paolillo S, Veglia F, Salvioni E, Corrà U, Piepoli M, Lagioia R, Limongelli G, Sinagra G, Cattadori G, Scardovi AB, Metra M, Senni M, Bonomi A, Scrutinio D, Raimondo R, Emdin M, Magrì D, Parati G, Re F, Cicoira M, Minà C, Correale M, Frigerio M, Bussotti M, Battaia E, Guazzi M, Badagliacca R, Di Lenarda A, Maggioni A, Passino C, Sciomer S, Pacileo G, Mapelli M, Vignati C, Clemenza F, Binno S, Lombardi C, Filardi PP, Agostoni P; MECKI Score Research Group (see Appendix).

Eur J Heart Fail. 2019 Feb;21(2):208-217. doi: 10.1002/ejhf.1364. Epub 2019 Jan 11.

10.

Mycotic coronary aneurysms.

Buono A, Maloberti A, Bossi IM, Piccaluga E, Piccalò G, Oreglia JA, Moreo A, Russo CF, Oliva F, Giannattasio C.

J Cardiovasc Med (Hagerstown). 2019 Jan;20(1):10-15. doi: 10.2459/JCM.0000000000000734. Review.

PMID:
30418268
11.

Reduction of heart rate in patients with heart failure aiming to improve ventricular-arterial coupling.

Buono A, Oliva F, Ammirati E.

Int J Cardiol. 2018 Aug 15;265:172. doi: 10.1016/j.ijcard.2018.04.106. No abstract available.

PMID:
29885684
12.

Predictors of atrial fibrillation in hypertrophic cardiomyopathy.

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.

PMID:
27794017
13.

The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.

Corrà U, Agostoni P, Giordano A, Cattadori G, Battaia E, La Gioia R, Scardovi AB, Emdin M, Metra M, Sinagra G, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Cicoira M, Salvioni E, Giovannardi M, Veglia F, Mezzani A, Scrutinio D, Di Lenarda A, Ricci R, Apostolo A, Iorio AM, Paolillo S, Palermo P, Contini M, Vassanelli C, Passino C, Giannuzzi P, Piepoli MF; MECKI Score Research Group; Other Members of the MECKI Score research Group, Antonioli L, Segurini C, Bertella E, Farina S, Bovis F, Pietrucci F, Malfatto G, Roselli T, Buono A, Calabrò R, De Maria R, Santoro D, Campanale S, Caputo D, Bertipaglia D, Berton E.

Int J Cardiol. 2016 Jan 15;203:1067-72. doi: 10.1016/j.ijcard.2015.11.075. Epub 2015 Nov 10.

PMID:
26638056
14.

Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score.

Carubelli V, Metra M, Corrà U, Magrì D, Passino C, Lombardi C, Scrutinio D, Correale M, Cattadori G, Piepoli MF, Salvioni E, Giovannardi M, Raimondo R, Cicoira M, Belardinelli R, Guazzi M, Limongelli G, Clemenza F, Parati G, Scardovi AB, Di Lenarda A, Bussotti M, La Gioia R, Agostoni P; MECKI score research group.

Circ J. 2015;79(12):2608-15. doi: 10.1253/circj.CJ-15-0026. Epub 2015 Oct 16.

15.

Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Eur J Heart Fail. 2015 Aug;17(8):837-45. doi: 10.1002/ejhf.316. Epub 2015 Jul 16.

16.

Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction.

Scrutinio D, Agostoni P, Gesualdo L, Corrà U, Mezzani A, Piepoli M, Di Lenarda A, Iorio A, Passino C, Magrì D, Masarone D, Battaia E, Girola D, Re F, Cattadori G, Parati G, Sinagra G, Villani GQ, Limongelli G, Pacileo G, Guazzi M, Metra M, Frigerio M, Cicoira M, Minà C, Malfatto G, Caravita S, Bussotti M, Salvioni E, Veglia F, Correale M, Scardovi AB, Emdin M, Giannuzzi P, Gargiulo P, Giovannardi M, Perrone-Filardi P, Raimondo R, Ricci R, Paolillo S, Farina S, Belardinelli R, Passantino A, La Gioia R; Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) Score Research Group.

Circ J. 2015;79(3):583-91. doi: 10.1253/circj.CJ-14-0806. Epub 2015 Jan 26.

17.

Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure.

Corrà U, Agostoni P, Piepoli MF; MECKI score research group.

Int J Cardiol. 2015 Apr 1;184:299-301. doi: 10.1016/j.ijcard.2015.02.070. Epub 2015 Feb 24. No abstract available.

PMID:
25731843
18.

Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation.

Magrì D, Agostoni P, Corrà U, Passino C, Scrutinio D, Perrone-Filardi P, Correale M, Cattadori G, Metra M, Girola D, Piepoli MF, Iorio A, Emdin M, Raimondo R, Re F, Cicoira M, Belardinelli R, Guazzi M, Limongelli G, Clemenza F, Parati G, Frigerio M, Casenghi M, Scardovi AB, Ferraironi A, Di Lenarda A, Bussotti M, Apostolo A, Paolillo S, La Gioia R, Gargiulo P, Palermo P, Minà C, Farina S, Battaia E, Maruotti A, Pacileo G, Contini M, Oliva F, Ricci R, Sinagra G; Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) Score Research Group.

Eur J Prev Cardiol. 2015 Aug;22(8):1046-55. doi: 10.1177/2047487314551546. Epub 2014 Sep 26. Erratum in: Eur J Prev Cardiol. 2016 Jul;23(11):NP97.

PMID:
25261267
19.

Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests.

Di Francia R, Siesto RS, Valente D, Del Buono A, Pugliese S, Cecere S, Cavaliere C, Nasti G, Facchini G, Berretta M.

Anticancer Drugs. 2013 Nov;24(10):1069-78. doi: 10.1097/CAD.0000000000000002. Review.

PMID:
24025562
20.

Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption.

Cattadori G, Agostoni P, Corrà U, Di Lenarda A, Sinagra G, Veglia F, Salvioni E, La Gioia R, Scardovi AB, Emdin M, Metra M, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Mezzani A, Scrutinio D, Pacileo G, Apostolo A, Iorio A, Paolillo S, Palermo P, Contini M, Giannuzzi P, Battaia E, Cicoira M, Passino C, Piepoli MF; MECKI score research group.

Int J Cardiol. 2013 Oct 12;168(5):5078-81. doi: 10.1016/j.ijcard.2013.07.192. Epub 2013 Jul 30. No abstract available.

PMID:
23962781

Supplemental Content

Loading ...
Support Center